Clinical Trial Update: Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy

View source ↗

Summary

A clinical trial update evaluating whether circulating tumor cells predict survival in hormone-refractory (castration-resistant) prostate cancer patients receiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Immunicon | Conditions: Hormone Refractory Prostate Cancer, Prostate Cancer | Status: UNKNOWN